The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  March 2019 Next
  • Protein-Protein Interactions 2019

    April 4-5, 2019   Leeds, United Kingdom

    Virtually all vital cellular processes are controlled by protein-protein interactions (PPIs), including gene expression, proliferation, intracellular communication and apoptosis. The understanding and manipulation of PPIs therefore plays an important role in fathoming the biology of healthy and diseased states. Achieving this goal will lead to new probes of cell signalling pathways or systems biology, and molecular therapeutics for addressing unmet medical need.

    To date, only a few PPIs have been the subject of drug discovery initiatives by the pharmaceuticals industry. Given the potential opportunities around modulating more of the estimated >650,000 PPIs, this field continues to generate considerable scientific interest, which has stimulated significant academic and industrial innovation. This meeting will address recent advances in the area. Topics will include: inducing protein degradation using small molecules, protein engineering and synthetic biology, integration of computational and experimental methods to study PPIs, characterisation and identification of new PPI inhibitors and lead optimization challenges for molecules targeting PPIs from case studies in drug discovery.Speakers from both industry and academia will describe strategies for addressing these challenges whilst showcasing the opportunity for creativity and innovation.

    Confirmed Speakers

    • Prof Craig Crews, Yale University, United States
    • Prof Amy Keating, Massachusetts Institute of Technology, United States
    • Dr Isabelle Landrieu, Universite de Lille, France
    • Dr Angelita Rebollo, Centre d'Immunologie et des Maladies Infectieuses, France
    • Dr Graeme Robb, AstraZeneca, United Kingdom
    • Prof Ali Tavassoli, University of Southampton, United Kingdom
    • Prof Dek Woolfson, University of Bristol, United Kingdom

    For more information: SCI Conferences Team
    Tel: +44 (0)20 7598 1561

25 26 27 28 01 02 03
04 05 06 07 08 09 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
01 02 03 04 05 06 07
All events   |  Future events

Job portal

Life Science Business Development Manager Europe Asia, Hybrigenics Services SAS: Business Development Europe Asia, Paris or European city, France
read more

Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRocheSanofiGalChimia
Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerckAstra ZenecaIdorsiaMercachemsyncom